Cargando…

The Relationships Between Hyperprolactinemia, Metabolic Disturbance, and Sexual Dysfunction in Patients With Schizophrenia Under Olanzapine Treatment

The aim of the study was to assess the relationship between prolactin levels and sexual dysfunction in patients with schizophrenia who use olanzapine medication. The potential risk factors of hyperprolactinemia and sexual dysfunction were also investigated. Patients with schizophrenia undergoing ola...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Tzu-Hua, Lin, Chieh-Hsin, Goh, Kah Kheng, Chen, Cynthia Yi-An, Chen, Chun-Hsin, Lane, Hsien-Yuan, Lu, Mong-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374865/ https://www.ncbi.nlm.nih.gov/pubmed/34421613 http://dx.doi.org/10.3389/fphar.2021.718800

Ejemplares similares

The Role of Adiponectin in the Pathogenesis of Metabolic Disturbances in Patients With Schizophrenia
por: Chen, Cynthia Yi-An, et al.
Publicado: (2021)

Efficacy and safety of intermittent theta-burst stimulation in patients with schizophrenia: A meta-analysis of randomized sham-controlled trials
por: Goh, Kah Kheng, et al.
Publicado: (2022)

Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
por: Goh, Kah Kheng, et al.
Publicado: (2022)

Olanzapine-Induced Hyperprolactinemia: Two Case Reports
por: Barata, Pedro Cabral, et al.
Publicado: (2019)

Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives
por: Chang, Shen-Chieh, et al.
Publicado: (2021)

Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment
por: Goh, Kah Kheng, et al.
Publicado: (2021)

Application of Plasma Levels of Olanzapine and N-Desmethyl-Olanzapine to Monitor Clinical Efficacy in Patients with Schizophrenia
por: Lu, Mong-Liang, et al.
Publicado: (2016)

Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia
por: Bise, S., et al.
Publicado: (2022)

Hyperprolactinemia and breast enlargement with serotonin reuptake inhibitor and olanzapine combination
por: Praharaj, Samir Kumar
Publicado: (2011)

Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients
por: Zhou, Wei, et al.
Publicado: (2019)

Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis
por: Zhu, Zhenyu, et al.
Publicado: (2022)

Sexual dysfunction in male schizophrenia remitted patients treated with risperidone and olanzapine
Publicado: (2022)

Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids
por: He, Sidi, et al.
Publicado: (2020)

Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
por: Huang, Jing, et al.
Publicado: (2020)

Determination of Olanzapine and N-desmethyl-olanzapine in Plasma Using a Reversed-Phase HPLC Coupled with Coulochemical Detection: Correlation of Olanzapine or N-desmethyl-olanzapine Concentration with Metabolic Parameters
por: Lu, Mong-Liang, et al.
Publicado: (2013)

Carnitine metabolites and cognitive improvement in patients with schizophrenia treated with olanzapine: a prospective longitudinal study
por: Zhao, Lei, et al.
Publicado: (2023)

Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
por: Huang, Jing, et al.
Publicado: (2020)

Sexual Dysfunction and Hyperprolactinemia in Male Psychotic Inpatients: A Cross-Sectional Study
por: Johnsen, Erik, et al.
Publicado: (2011)

C-reactive protein is associated with severity of thought and language dysfunction in patients with schizophrenia
por: Chang, Chun-Hung, et al.
Publicado: (2019)

Pulmonary Artery Occlusion and Mediastinal Fibrosis in a Patient on Dopamine Agonist Treatment for Hyperprolactinemia
por: Su, Junjing, et al.
Publicado: (2017)

Effects of low-dose combined olanzapine and sertraline on negative and depressive symptoms in treatment-resistant outpatients with acute exacerbated schizophrenia
por: Lang, Xiaoe, et al.
Publicado: (2023)

Serotonin and dopamine receptors in motivational and cognitive disturbances of schizophrenia
por: Sumiyoshi, Tomiki, et al.
Publicado: (2014)

Effects of Renaming Schizophrenia on Destigmatization among Medical Students in One Taiwan University
por: Chiu, Yi-Hang, et al.
Publicado: (2021)

Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia
por: Liu, Jiahong, et al.
Publicado: (2021)

Renaming Schizophrenia and Stigma Reduction: A Cross-Sectional Study of Nursing Students in Taiwan
por: Chiu, Yi-Hang, et al.
Publicado: (2022)

Comparative study of sexual dysfunction and serum prolactin level associated with olanzapine, risperidone, and clozapine in patients with remitted schizophrenia
por: Sathish Kumar, S. V., et al.
Publicado: (2015)

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
por: An, Huimei, et al.
Publicado: (2022)

Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences
por: Chen, Chien-Yu, et al.
Publicado: (2016)

The prevalence of thyroid dysfunction and hyperprolactinemia in women with PCOS
por: van der Ham, Kim, et al.
Publicado: (2023)

Hyperprolactinemia
por: Majumdar, Abha, et al.
Publicado: (2013)

Vitamin D supplementation is effective for olanzapine-induced dyslipidemia
por: Zhou, Zijian, et al.
Publicado: (2023)

Neutropenia after the coadministration of clozapine and nirmatrelvir-ritonavir in a patient with SARS-CoV-2 infection: A case report with a literature review
por: Liu, Chun-I, et al.
Publicado: (2022)

Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment
por: Hung, Chung-Chieh, et al.
Publicado: (2021)

Effects of TNF-α on penile structure alteration in rats with hyperprolactinemia
por: Wang, Zhong-Lin, et al.
Publicado: (2017)

A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine
por: Nagaraj, Anil Kumar M., et al.
Publicado: (2009)

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
por: Tasaki, Minami, et al.
Publicado: (2021)

Metabolic Abnormality and Sleep Disturbance are Associated with Clinical Severity of Patients with Schizophrenia
por: Hung, Chung-Chieh, et al.
Publicado: (2014)

Zero confirmed cases: The ways we curb COVID-19 in Taiwanese prisons
por: Goh, Kah Kheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f94u9l9q5i5utfgo9aljmr2keo